Adamantinoma Metastasis to the Pelvis and Ovaries: A Case Report and Literature Review.

Autor: Amin T; Surgical Oncology Department, Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, SAU., Azzam AZ; General Surgery Department, Faculty of Medicine, Alexandria University, Alexandria, EGY.; Surgical Oncology Department, Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, SAU., AlBatati SK; Orthopedic Surgery, King Fahad Military Medical Complex, Dhahran, SAU.; College of Medicine, Alfaisal University, Riyadh, SAU., AlHossan AM; Orthopedic Surgery, King Fahad Military Medical Complex, Dhahran, SAU.; College of Medicine, Alfaisal University, Riyadh, SAU.
Jazyk: angličtina
Zdroj: Cureus [Cureus] 2023 Dec 06; Vol. 15 (12), pp. e50087. Date of Electronic Publication: 2023 Dec 06 (Print Publication: 2023).
DOI: 10.7759/cureus.50087
Abstrakt: Adamantinoma, constituting a minute fraction of primary bone tumors, poses a diagnostic challenge due to its ambiguous histogenesis. This report outlines a distinctive case involving a 27-year-old female with a history of right tibial adamantinoma, presenting with bilateral pulmonary emboli and metastasis to the ovaries and pelvic lymph nodes. Following en bloc resection five years earlier, the patient underwent debulking surgery with hyperthermic intraperitoneal chemotherapy (HIPIC) and intraoperative radiotherapy (IORT) as a palliative measure. The procedure achieved substantial pelvic tumor reduction, and subsequent follow-ups indicated a favorable postoperative trajectory. This case underscores the rarity of adamantinoma metastasis to the ovaries and pelvis, being the first reported instance, shedding light on the challenges and potential benefits of a multimodal palliative approach. Further research is warranted to refine treatment strategies for metastatic adamantinoma and enhance patient outcomes.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2023, Amin et al.)
Databáze: MEDLINE